Is Pfizer A Good Stock To Buy -

For many, the primary reason to hold Pfizer is its status as a premier income stock.

: Following its $43 billion acquisition of Seagen, Pfizer is now a powerhouse in oncology. Cancer-fighting drugs now account for roughly 27% of total revenue , with the company aiming for eight blockbuster oncology medicines by 2030. is pfizer a good stock to buy

To help you decide if Pfizer aligns with your portfolio, we’ve broken down the current financial health, growth drivers, and risks based on recent market data and analyst consensus. For many, the primary reason to hold Pfizer

: The stock is currently trading at a forward price-to-earnings (P/E) ratio of roughly 9.3x to 9.4x . This is well below its five-year mean and significantly cheaper than industry peers like Eli Lilly or Novo Nordisk. To help you decide if Pfizer aligns with

: As of late April 2026, Pfizer offers a robust forward dividend yield of approximately 6.3% to 6.4% . This significantly outpaces the broader pharmaceutical sector average.